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Stlmmal~ 
The murine acquired immunodeficiency syndrome (MAIDS) caused by defective LP-BM5 murine 
leukemia virus (MuLV) is a disease that shows severe immunodeficiency with abnormal lympho- 
proliferation,  and hypergammaglobulinemia  in susceptible C57BL/6 (B6) mice. To examine the 
cellular mechanisms of development of MAIDS,  we injected LP-BM5 MuLV intraperitoneaUy 
into B6 mice bearing the X chromosome-linked immunodefidency  (xid). xid mice lack functionally 
mature B cells including Ly-1 B cells (also known as B-1 cells). All B6 mice died by 20 wk 
after LP-BM5 MuLV inoculation. In marked contrast, xid mice have continued to survive without 
any sign of MAIDS-related  symptoms till at least 20 wk after the inoculation.  The delayed 
progression of  MAIDS in x/d mice appears to depend on xid mutation, according to our experiments 
using both sexes of (B6.xid  x  B6)F1 and (B6  x  B6.xid)F1 mice. Furthermore, Ly-1 B cells, 
enriched by a FACS  |  were shown to integrate the defective genome and appeared to be a major 
virus-infected B cell population.  Our data corroborate that Ly-1 B cells play an important role 
in the induction and progression  of MAIDS. 
T 
he  murine  acquired  immunodeficiency  syndrome 
(MAIDS) 1 caused by a defective retrovirus  (defective 
LP-BM5 murine leukemia virus [MuLV]) (1, 2), which en- 
codes a gag fusion protein (Pr60S~s), is a disease that shows 
many similarities with human AIDS, in particular abnormal 
lymphoproliferation, polyclonal B cell activation, and severe 
immunodeficiency  (3, 4). Previous studies have proven that 
complex cellular interactions between T and B cells are re- 
quired for the induction and development of MAIDS. B cell 
abnormalities  are shown in the presence of T cells of CD4 
phenotype (5), whereas B cells are required for induction of 
phenotypic and functional T cell abnormalities  in MAIDS 
(6). It is interesting that a recent study reported that the 
majority of cells infected with the defective LP-BM5 MuLV 
1  Abbrrviations used in this paper: MAIDS, murine  acquired immunode- 
ficiency  syndrome;  MuLV, murine  leukemia  virus; xid, X-linked  immu- 
nodeficiency. 
belongs to B cell lineages (7, 8), implying that B cells trigger 
the induction and development of  MAIDS. The development 
of hypergammaglobulinemia in MAIDS also suggests that 
B cell activation and its differentiation is associated with the 
induction of MAIDS. 
It still remains obscure, however,  what kinds orB cell subsets 
are required for and involved in the induction and develop- 
ment of MAIDS.  To examine these problems, we used the 
X-linked immunodeficient (xic  0 mice (9-12). The defects in 
x/d mice, which show the impaired humoral immune response 
to type II T cell independent antigens (9, 10, 12), has been 
implicated in the arrest of functional maturation of B cells. 
In particular, the lack of Ly-1 B cells (also known as B-1 cells 
[13]) is noticed in xid mice (11). 
Here we report that xid mice are resistant to MAIDS and 
Ly-1 B cells are a major virus-infected B cell population.  Our 
data corroborate that Ly-1 B cells play an important role in 
the development  of retrovirus-induced  immunodeficiency, 
MAIDS. 
621  J. Exp. Med. ￿9 The Rockefeller  University  Press ￿9 0022-1007/93/03/0621/06 $2.00 
Volume 177  March  1993  621-626 Materials and Methods 
Mice.  B6.xid mice were kindly provided by Dr. Alfred Singer 
(National Institutes of Health (NIH), Bethesda, MD) through Dr. 
Toshiyuki Hamaoka (Osaka University Medical School, Osaka, 
Japan) and maintained in the animal facility  in Kumamoto Univer- 
sity under specific  pathogen free conditions. It is unclear how far 
the xid gene was backcrossed onto the B6 background. But these 
mice show a defect in the response to TNP-Ficoll and the number 
of Ly-1  + B cells (Hitoshi, Y., E. Sonoda, Y. Kikuchi, S. Yonehara, 
H. Nakauchi, and K. Tahtsu, manuscript submitted for publica- 
tion). B6 mice were purchased from Japan SLC Inc. (Hamamatsu, 
Japan). 
LP.BM5 MuLV.  An SC-1 done chronically infected with LP- 
BM5 MuLV, termed G6 cell line, was kindly supplied by H. C. 
Morse III (NIH). Virus was prepared from the superuatant of G6 
cells. A 24-h culture supernatant of G6 ceils contained '~5  x  104 
PFU of  ecotropic virus per ml, determined by the XC phque assay 
described by Rowe et al. (14). The virus preparation was stored 
at  -70~  until use. 
Analyses of Development of MAIDS.  B6  mice, B6.xid  mice, 
(B6.xid  x  B6)F1 mice and (B6  x  B6.xid)F1 mice were injected 
intraperitoneally with 104 PFU of LP-BM5 MuLV. At 7 wk after 
the injection, the spleen weight, the amount of serum IgM, and 
proliferative  response of spleen  cells to Con A were measured. The 
serum IgM level was determined by isotype-specific  ELISA. Con 
A response was  monitored by [3H]thymidine incorporation of 
spleen cells (10  s) in the presence of Con A (2/~g/ml) for the last 
12 h of 2-d culture. 
Detection of the Defective  LP-BM5 MuLV Genome by PCR.  Tem- 
plate DNAs extracted from spleen cells (10  s) of the mice at 7 wk 
after the virus inoculation were amplified by PCR as described 
previously (15). The PCR primers were 5'-CCTCTTCCTTTA- 
TCGACACT-3' and 5'-ATTAG~GGAATAGCTCG-3'. These 
primers correspond to the sequences located in the defective LP- 
BM5 MuLV  gag-encoded gene, p15 and p12, respectively.  Template 
DNAs were added to a cocktail adjusted to final concentrations 
of 10 mM Tris-HC1 (pH  8.3), 50 mM KC1, 1.5 mM MgC12, 
0.01% gelatin, 200 #M deoxynucleoside  triphosphate, 100 pM of 
each primer, and 2 U of Taq DNA polymerase  (Boehringer Mann- 
heim, Mannheim, Germany) in a total volume of 100/~1, and were 
subjected to 30 cycles of amplification. In each cycle  of PCR, the 
mixture was denatured at 95~  for 1 rain (5 rain for the first cyde), 
annealed at 55~  for 3 min, and extended at 72~  for 1 min on 
a programmed  temperature  control system  (Astec, Fukuoka,  Japan). 
The PCR products (237 bp) were then analyzed  by Southern blot 
hybridization with an internal probe, 5'-TGTCAAAGGGACC- 
AGTTAAG-3'. The  PCR can  detect  one infected cell among 
104-105 cells. As control, DNA from mouse Ib5 receptor (IL-5R) 
tx chain was amplified  by PCR in the same methods. The primers 
used for PCR reaction were 5'-AAACCTTCGAATGAAACCA-3' 
and 5'-TGGTATTAAAGGCGAGCTC-3',  and define fragments of 
216 bp. These primers correspond to the sequences located in the 
cytoplasmic domain and 3'-uncoding region of IL,5R c~ chain, 
respectively (16). 
Abs  and Reagents.  The  following monoclonal Abs  (mAbs) 
were used: RA3-6B2 mAb (rat IgG2a), which recognizes B220 
(American Type  Culture Collection, Ikockville,  MD); 53-7.3 mAb 
(rat IgG2a), which recognizes Ly-1 (American Type Culture Col- 
lection); 2.4G2 mAb (rat IgG1), which recognizes murine FcylL 
(American Type Culture  Collection).  Each mAb  was purified 
from ascitic fluids with protein G-column (Pharmacia-LKB  Lab- 
oratories, Uppsala, Sweden). PE-labded streptavidin (PE-av) was 
purchased from Becton Dickinson & Co. (Mountain View, CA). 
Staining and Sorting of Ly-1 +B220  § Cells.  Cells  from inguinal 
LNs of B6 mice at 14 wk after the LP-BM5 MuLV inoculation 
were stained with biotinylated anti-Ly-1 mAb  plus PE-av and 
FITC-hbded anti-B220 mAb (RA3-6B2). The stained cells were 
analyzed by a FACStar  |  (Becton Dickinson &  Co.) and frac- 
tionated  into  Ly-l-B220-,  Ly-l+B220  -,  Ly-1-B220  +,  Ly-1  +- 
B200 + and unseparated. The cells (104) of sorted fractions were 
investigated for the detection of defective  LP-BM5 MuLV genome 
and DNA from IbSK ce chain as described above. 
Results 
C57BL/6 (B6)  mice are  highly susceptible  to LP-BM5 
MuLV (this represents  a mixture of the replication-defective 
virus and the ecotropic helper virus) and develop  MAIDS 
in several weeks after viral infection (17, 18). We injected 
LP-BM5 MuLV intraperitoneally into B6 mice or B6 mice 
bearing the X chromosome-linked imm~odefidency (B6.x/d). 
As shown in Fig.  1,  all B6 mice died within 20 wk after 
LP-BM5 MuLV inoculation with changes characteristic  of 
MAIDS. In marked contrast, B6.xid mice have continued to 
survive without any sign of MAIDS-related symptoms such 
as splenomegaly, lymphadenopathy, and hypergammaglob- 
ulinemia till at least 20 wk after the inoculation of LP-BM5 
MuLV. Less than 30% of the virus-inoculated-B6.xid  mice 
died with splenomegaly and lymphadenopathy 30 wk after 
the virus inoculation. 
To investigate whether the delayed progression of MAIDS 
in B6.x/d mice depends on xid mutation, both sexes of (B6.xid 
x  B6)F1 and (B6  x  B6.xid)F1 mice were inoculated with 
LP-BM5 MuLV. Since xid mutation is X-chromosomal reces- 
sive, (B6.xid  x  B6)F1 male mice (xid/Y genotype) only ex- 
press the defects of  x/d mutation. The extent of splenomegaly, 
elevation of serum IgM level, and impaired Con A-response 
were examined in each group of mice 7 wk after LP-BM5 
MuLV inoculation. As shown in Table 1, B6.x/d and the defec- 
tive F1 male mice were flee of the MAIDS-related symp- 
toms, whereas the other groups of mice showed the marked 
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Figure  1.  Survival  of B6 (solid line) and B6.xid mice (dotted line) after 
the inoculation  of LP-BM5 MuLV. B6 mice (n  = 20) and B6.xid mice 
(n = 15) were injected intraperitoneally  with LP-BM5  MuLV  at 5-6 wk 
of age. 
622  Delayed  Progression of MAIDS in xid Mice Table  1.  Delayed  Progression of MAIDS in xid Mice 
LP-BM5 
Mice  Sex  Genotype  infection  Spleen  IgM  Con  A  response 
rag  ~g/ml  cpm 
B6  F  X/X  -  81  -+  16  650  _+  300  40,635  _+  191 
+  593  +  106  3,551  _+  1,432  1,187  _+  103 
xid  F  xid/xid  -  63  _+  13  47  _+  14  ND 
+  67  _+  17  35  _+  11  ND 
xid  x  B6  M  xid/Y  -  58  +  18  34  +  21  55,090  _+  1,731 
+  70  +  20  67  +  42  52,372  _+  2,035 
xid  x  B6  F  xid/X  -  78  _+  10  325  _+  183  46,725  _+  630 
+  344  +  51  1,022  _+  501  1,315  _+  197 
B6  x  xid  M  X/Y  -  63  _+  10  310  _+  106  38,252  _+  9,878 
+  578  _+  56  1,791  +  322  769  +  132 
B6  x  xid  F  X/xid  -  74  _+  10  263  +  94  52,860  +  9,516 
+  492  +  77  1,739  _+  730  1,580  _+  482 
B6 mice, B6.xid mice, (B6.xid x  B6)FI mice, and (B6  x  B6.xid)F1 mice were injected intraperitoneaUy with LP-BM5 MuLV. At 7 wk after the 
injection,  the spleen weight,  the amount  of serum lgM and proliferative response of spleen cells to Con A were measured. The serum IgM level 
was determined by isotype-specific  ELISA. Con A response was monitored by [3H]thymidine incorporation of spleen cells (10  s) in the presence of 
Con A (2 #g/ml) during  the  12 h after 2-d culture.  Data were expressed as mean  +  SD of five mice. 
symptoms. These results further  supported  the notion  that 
xid mutation  is  responsible  for the  delayed  progression  of 
MAIDS. 
We then investigated the integration  of the defective LP- 
BM5 MuLV genome in spleen cells (Table 1). The defective 
LP-BM5  MuLV has a long open reading flame encoding  a 
putative gag precursor protein.  A gag protein, gag p12, was 
the most divergent in comparison with that of nondefective 
MuLV (2). The unique DNA sequence encoding the gag p12 
protein  of defective LP-BM5  MuLV was  detected  by PCR 
and Southern blot hybridization.  As shown in Fig.  2, PCR 
product  of the defective LP-BM5  MuLV  gene was  not  de- 
tected in B6.xid and  the Ft  male mice 7  wk  after LP-BM5 
MuLV  inoculation,  whereas  the  PCR  product  was  clearly 
shown in the other groups of mice. Since the defective LP- 
BM5  MuLV has proven to be the disease (MAIDS)-causing 
virus,  it  is conceivable that  mice bearing  the xid mutation 
are resistant  to the defective virus infection.  Several B6.xid 
mice showed splenomegaly and lymphadenopathy 30 wk after 
the  virus inoculation  (Fig.  1).  These  mice  showed  the  in- 
tegration  of the  defective LP-BM5  MuLV  genome  in cells 
of the enlarged spleen (data not shown). In addition, we could 
detect a weak expression of the defective LP-BM5 MuLV ge- 
nome without remarkable MAIDS-related symptoms 20 wk 
after virus inoculation in B6.xid mice tested (data not shown). 
An apparent correlation between the xid mutation and re- 
Figure  2.  Detection  of the defective  LP-BM5  MuLV 
genome by PCK. The template DNAs were extracted 
from spleen cells (106) of B6 mice, B6.xid mice (x/d), 
(xid x  B6)F1 mice, and 036  x xid)F1  mice 7 wk after 
the virus inoculation, and were amplified by PCR. 
The PCR products (237 bp) were then analyzed by 
Southern blot hybridization. 
623  Hitoshi et al. Figure  3.  Detection of the defective LP-BM5 MuLV genome in Ly-1 B cells by PCK and Southern blot hybridization. (a) Cells from inguinal LN 
of B6 mice 14 wk after the LP-BM5 MuLV inoculation were stained with biotinylated anti-Ly-1 mAb plus PE-labded streptavidin and FITCqabeled 
anti-B220 mAb. The stained cells were analyzed by a FACStar  |  and fractionated into Ly-1-B220-, Ly-1  +B220-, Ly-1-B220 + , Ly-1  +B220 +  , and un- 
separated.  Percentages  of stained cells in the gated windows of each fraction were shown in a corner of each window. (b) The cells (104) of sorted 
fractions were investigated  for the detection of defective LP-BM5 MuLV genome as described in Materials and Methods. (Lane I) Unseparated cells; 
(lane 2) Ly-l-B220- cells; (lane 3) Ly-l+B220  -  cells; (lane 4) Ly-l-B220 + cells; (lane 5) Ly-l+B220  + cells. (c) The cells (10  ~) of sorted fractions 
were investigated for the detection of DNA from Ib5 receptor tx chain as described in Materials and Methods. (Lane 1) Unseparated cells; (lane 2) 
Ly-l-B220-  cells; (lane 3) Ly-l+B220  -  cells; (lane 4) Ly-l-B220 + cells; (lane 5) Ly-l+B220  + cells. 
sistance to MAIDS development was found in this study. Since 
lack ofLy-1 B cells in xid mice has been noticed, the question 
was whether the lack of Ly-1 B  cells is responsible for the 
delayed progression of MAIDS in xid mice. In fact, the B6.xid 
mice have few Ly-1 B cells in the peritoneal cavity and spleen 
(data not shown). To address whether Ly-1 B  cells are the 
target cells of defective LP-BM5 MuLV, we enriched Ly-1 B 
cells by FACStar  |  from LN cells of B6 mice infected with 
LP-BM5 MuLV, and analyzed the integration of the defec- 
tive genome in Ly-1 B cells by the same method used in Fig. 
2. Fig. 3 a shows FACS  |  profiles and the purity in each sorted 
fraction. Fig. 3  b dearly showed that the defective genome 
was detected in unfractionated cells (lane  1),  Ly-l+B220 + 
cells (Ly-1 B cells)  (lane 5), and Ly-1-B220-  cells (lane 2), 
and slightly in Ly-l-B220 + cells (lane 4), whereas the ge- 
nome was not found in Ly-1 +  B220-  cells (T cells)  (lane 3). 
In contrast, DNA from Ib5R tx chain was similarly detected 
in reaction performed with materials from unfractionated cells 
(lane  I),  Ly-1-B220-  cells  (lane 2),  Ly-l+B220 -  cells  (T 
cells)  (lane 3), Ly-1-B220 + cells (lane 4),  and Ly-1 +  B220 + 
cells (Ly-1 B cells) (lane 5) (Fig. 3 c). These results indicated 
that Ly-1 B cells were infected with the defective LP-BM5 
MuLV. 
Discussion 
We clearly demonstrated that B6.xid mice did not show 
any signs of MAIDS-associated  symptoms 20 wk after the 
LP-BM5 MuLV infection, although B6 mice show the symp- 
toms within  7 wk after the MuLV infection at  the latest. 
The defective LP-BM5 MuLV was not detected using PCR 
and Southern blot hybridization in B6.xid mice 7 wk after 
inoculation. These results suggest that xid mutation affects 
the induction and development of MAIDS. In addition, the 
cell sorting experiments suggest that Ly-1 B cells are the target 
cell population for the defective LP-BM5 MuLV. In light of 
our finding, we can hypothesize that Ly-1 B cells play an im- 
portant role in the induction and progression of MAIDS and 
the lack of Ly-1 B cells in B6.xid mice may account for the 
delayed progression of LP-BM5 MuLV infection in xid mice. 
Ly-1 B cells, which are characterized by the expression of 
surface markers such as Ly-1 +, slgMb~g  h', slgD  aun, B220  dull, 
and Mac-l+,  constitute a distinct B cell lineage and differ 
in their functional properties from conventional B cells (11, 
19). Huang reported that the majority of the LP-BM5 MuLV- 
infected cells are B220  aun positive,  not  B220b~g  ht cells  (8). 
Their  B220  a~l cells may be Ly-1  B  cells.  And it  has been 
reported that all B-lineage cells established in culture from 
LP-BM5 MuLV-infected mice are Ly-l-positive (20), and these 
cells show the expression of multiple copies of the defective 
virus (21).  These reports may support our data that Ly-1 B 
cells are target  cells for the defective LP-BM5  MuLV. 
Several characteristics of Ly-1 B cells could contribute to 
the development of MAIDS. First, we notice that Ly-1 B cells 
have a self-renewal ability (22). Huang et al. (8, 23) reported 
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tire virus that cannot replicate  on its own. The expansion 
of target ceUs should be necessary for the development of 
MAIDS in their system. Cheung et al.  (24) reported that 
the levels of transcripts encoded by ecotropic LP-BM5 MuLV 
(helper virus) were lower than those of defective LP-BM5 
MuLV. Their findings also suggest that cell populations ex- 
pressing defective LP-BM5 MuLV may be amplified, in part, 
by ceU division, as well as by continuing infection of naive 
cells. The virus-infected Ly-1 B cells could expand themselves 
and develop MAIDS. Second,  O'Garra et al. (25) reported 
that Ly-1 B calls are the main source of B cell-derived IL-10, 
which suppresses cytokine production by Thl-type CD4 + 
T ceUs and macrophages (26, 27) and has B cell stimulatory 
activity (28). In fact, Gazzinelli et al. (29) reported that II.-10 
is produced during progression of MAIDS. LP-BM5 MuLV-in- 
fected Ly-1 B cells may be responsible for producing IL-10, 
which could provoke persistent activation of Th2-type T ceUs, 
downregulate the production of Thl-derived cytokines, im- 
pair CD8 + T  cell function, and lead to chronic B cell acti- 
vation in LP-BM5 MuLV infection. Third, Van de Velde et 
al. (30) demonstrated that Ly-1 (CD5) and Lyb-2 (CD72), 
the activated B cell surface proteins are involved in the B cell 
activation process as a pair of interacting receptors. It has been 
postulated that virus-infected Ly-1 B cells hdp the activation 
of conventional B cells in the development of MAIDS (30) 
in which Ly-1/Lyb-2  interaction may be involved.  Collec- 
tively, Ly-1 B cells seem to be very important for the rapid 
development of MAIDS. 
It is intriguing that <30% of the virus-inoculated-B6.xid 
mice develop MAIDS 30 wk after the virus inoculation. These 
data suggest that the development of MAIDS depend on not 
only Ly-1 B cells but also other target cells ofLP-BM5 MuLV. 
It is interesting that B6.xid mice had a few Ly-1 B sister 
cells (known as B-lb cells [13]) that share several functional 
features  of Ly-1 B cells such as surface phenotypes, an un- 
usual IgM/IgD ratio, certain specificities to antigen, and dis- 
tinctive anatomical localization, though we do not show the 
data.  These cells in xid mice may play the same role as for 
Ly-1 + B cells in normal mice, but because of their low fre- 
quency, the progression of MAIDS is delayed. It was reported 
that macrophages from mice with MAIDS express viral RNA 
coded by ecotropic and defective LP-BM5 MuLV (31). Our 
experiments indicated that  Ly-l-B220-  cells  were other 
target cells of LP-BM5 MuLV. These cell populations may 
include macrophages. The development of MAIDS in x/d mice, 
though delayed, may be induced by the virus-infected mac- 
rophages. Recent studies demonstrated the presence of trans- 
plantable T-lymphoid  cells, which integrated the defective viral 
genome, in C57BL/6 mice infected with LP-BM5 MuLV (4, 
32). These cells may also be involved in the development of 
MAIDS. But we could not detect the defective virus in the 
Ly-1 +B220- cell population, which corresponds to T lym- 
phoid cells (Fig. 3). This discrepancy raises the possibilities 
that the transplantable T-lymphoid cells may be Ly-1- cells 
or the frequency of the T-lymphoid cells infected with the 
defective virus may be too low, i.e., below 1/10,000, to de- 
tect the virus genome from Ly-l+B220 -  cells. 
Failure to exhibit disease in xid mice was due to a block 
in virus replication (Fig. 2). The inability to exhibit integra- 
tion of the defective genome in disease raises the possibility 
that there may have been a block to spread of helper virus 
and impaired helper restriction may contribute to the drayed 
progression of MAIDS in xid mice. Ly-1 B cells may con- 
tribute to the replication of helper virus, although we do not 
have the data about the level of helper virus in Ly-1 B cells. 
The kinetics of appearance of the defective virus and helper 
virus in xid mice would be of interest. 
In condusion, we provide evidence in the present study 
that Ly-1 B cells are required for the progression of MAIDS, 
although the involvement of Ly-1 B cells may not be sufhcient. 
The ceUular mechanisms for the induction of a mouse retro- 
virus-induced immunodeficiency  have not been fully covered 
and need further investigation, our findings would provide 
a clue to approach this important issue and help in ducidating 
the pathogenesis of retrovirus-induced immunodefidency  syn- 
dromes including AIDS. 
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